Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Silent Stroke During TAVR and Early Cognitive Impairment

Silent stroke is common after transcatheter aortic valve replacement (TAVR). Co-morbidities such as diabetes or chronic renal failure, as well as procedural factors such as pre-dilation, increase the risk of silent stroke.

Es un hecho: la protección cerebral en TAVI logró demostrar que reduce el stroke y la muerte

While many events of silent stroke have an early effect on cognition, it is necessary to learn whether the impairment is sustained over time—specially in lower-risk populations with longer life expectancy. Cerebral protection devices do not seem to significantly reduce the issue.

In this paper, a systematic search of every study reporting the incidence of silent cerebral lesions detected in post-TAVR diffusion MRI was conducted. The amount of new silent lesions, baseline characteristics of patients, and incidence of early cognitive impairment were evaluated.

A total of 39 studies with said characteristics were identified. They included over 2000 patients who met inclusion criteria and had undergone a diffusion MRI after TAVR.

Surprisingly, 1601 patients experienced at least one new silent cerebral lesion. However, the clinical significance of these new lesions only reached 3%.

The analysis of co-morbidities analysis showed that diabetes, chronic renal failure, evaluations with 3T equipment, and pre-dilation were associated with a higher risk of silent imaging.


Read also: Short Therapy and Monotherapy, Plenty of Evidence.


Prevalence of early cognitive impairment at one-year rose from 16% at 10.0 ± 6.3 days to 26% at 6.1 ± 1.7 months. The number of new silent cerebral lesions was also linked to early cognitive impairment, evidencing an association between the mean number of silent lesions and the incidence of impairment.

Using different cerebral protection devices during the procedure seems to reduce the number of lesions, but not the incidence of cognitive impairment.

Conclusion

Post-TAVR silent stroke is a common event. Co-morbidities such as diabetes and pre-dilation increase the chances of its occurrence.

While more new lesions negatively impact impairment, longer-term follow-up is needed to expand in younger populations. The use of brain protection devices does not seem to be clinically useful.

Original Title: Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.

Reference: Kei Woldendorp et al. European Heart Journal (2021) 42, 1004–1015 doi:10.1093/eurheartj/ehab002.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...